Paparini, Sara
Hayes, Rosalie
Kasadha, Bakita
Apea, Vanessa
Burns, Fiona
Orkin, Chloe
,
Article History
Received: 27 May 2025
Accepted: 19 November 2025
First Online: 23 December 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and approved by City & East London Research Ethics Committee on 14 April 2022 (REC 22/PR/0318). Participants received a £15 voucher for participating in the survey and a £50 voucher for participating in the interview, with the amounts reflecting the inherent challenges of including people in a study about non-participation.
: Not applicable.
: SP has received research grants from ViiV Healthcare and Gilead Sciences. BK has received speaker honoraria and consultancy fees from Gilead Sciences, GSK, and ViiV Healthcare. VA has received speaker fees from ViiV Healthcare, Gilead Sciences and MSD. FB has received speakers fees from Gilead Sciences and research grants from Gilead Sciences, ViiV Healthcare and MSD. CMO has received honoraria for advisory boards, lectureships, and travel sponsorships from Janssen, Gilead Sciences, ViiV Healthcare, MSD and Bavarian Nordic and has received research grants from Janssen, Gilead Sciences, ViiV Healthcare, MSD and AstraZeneca. RH has no interests to declare.